Login / Signup

Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns.

Joseph ElijahIgor PuzanovBenjamin CresantiLamya HamadKristopher AttwoodKayla CatalfamoGrazyna Riebandt
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Clinicians ought to be aware of differences in the irAE profiles between nivolumab regimens with differing dosing patterns.
Keyphrases
  • palliative care
  • type diabetes
  • metabolic syndrome
  • insulin resistance
  • skeletal muscle
  • weight loss
  • glycemic control